设为首页    加入收藏   
首页期刊介绍编委会投稿须知稿约期刊订阅广告合作联系我们留言板

《中国冶金工业医学杂志》 欢迎访问,欢迎查询,欢迎引用!敬告作者投稿成功的标志是收到邮件回执。投稿出现问题邮箱wangtaohong@wangkantong.com,网站技术支持QQ1172987239。

本刊对投稿新要求:1.如果作者是第一次投稿,请务必用自己邮箱注册,并请认真填写作者单位详细通讯地址和第一作者手机,以便能及时准确收到杂志。2.文章必须有中文摘要,近5年参考文献至少3条。详见本刊投稿须知。本刊已同“中国知网”签订独家上网协议。

本刊2024年第3期杂志正在快递寄出,如果有作者没有收到杂志请与本刊编辑部联系,说明第一作者姓名和联系方式。

本刊2024年第3期杂志基本信息已经登载在本刊网站,欢迎读者、作者查询引用。

McNeal分带激光剜切汽化术对中重度前列腺增生症患者的尿控及射精功能保护作用研究*
作者:万里 王勇# 王树斌 唐芮鹏 魏绪磐 钟能 易正金 刘翔宇 罗云 
单位:攀钢集团总医院泌尿外科 四川 攀枝花 617023 
关键词:良性前列腺增生 基于McNeal分带法的经尿道前列腺激光剜切汽化术 经尿道前列腺等离子剜除术 McNeal分带法 尿控 性功能保护 
分类号:R 697+.3
出版年,卷(期):页码:2023,40(3):249-252
摘要:

 摘要:目的 探讨McNeal分带激光剜切汽化术(M-TULIP)对中重度前列腺增生症(BPH)患者的尿控及射精功能保护效果。方法 采用前瞻性、单中心的研究方法,将2019年1月—2021年12月本院收治的174例行M-TULIP治疗的中重度BPH患者作为实验组,154例经尿道前列腺等离子剜除术(TURP)治疗的BPH患者作为对照组。根据术前估算的前列腺体积将患者再分为中度增生实验组(EM组)99例,中度增生对照组(CM组)94例,重度增生实验组(EL组)75例,重度增生对照组(CL组)60例。比较4组围术期相关指标、腺体切除率、术后并发症发生情况、勃起功能障碍(ED)和射精功能障碍(EjD)的发生率以及手术前后各评价量表评分、最大尿流率(Qmax)、残余尿量(PVR)。结果 EM与CM组、EL与CL组、EM与EL组、CM与CL组的围术期相关指标、腺体切除率比较,差异均有统计学意义(均P<0.05);EM组并发症发生率低于CM组,EL组并发症发生率低于CL组,组间比较差异均有统计学意义(χ2=3.888、6.371,均P<0.05);实验组ED、EjD的发生率均明显低于对照组,组间比较差异均有统计学意义(χ2=66.024、165.270,均P<0.05);实验组和对照组术后Qmax、国际前列腺症状评分(IPSS)、生活质量评分(QoL)、PVR指标均较术前明显改善;EM组和EL组术后的IIEF-5评分、CIPE评分与术前比较,差异均无统计学意义(均P>0.05);EM组与CM组、EL组与CL组的术后IIEF-5评分、CIPE评分比较,差异均有统计学意义(t=12.351、27.008、6.167、21.748,均P<0.05)。结论 M-TULIP与TURP具有基本相当的手术疗效。但M-TULIP的组织切除率更低,手术时间、术中出血量、住院时间、留置尿管时间等指标均优于TURP,且术后尿失禁、EjD、ED、尿道狭窄等发生率显著低于TURP。故对于中重度BHP患者,并非需要追求更高的切除比率及切除重量。M-TULIP具有临床应用优势,值得推广。

 Abstract:Objective To investigate the urinary control and ejaculation function protection of McNeal band laser enucleation and vaporization in patients with anterior moderate to severe benign prostatic hyperplasia (BPH). Methods Using a prospective, single-centre study, a total of 174 patients with moderate-to-severe BPH treated with M-TULIP admitted to our hospital from January 2019 to December 2021 were used as the experimental group, and 154 patients with BPH treated with transurethral plasma enucleation of prostate (TURP) were used as the control group. The patients were subdivided into 99 patients in the experimental group with moderate hyperplasia (EM group), 94 patients in the control group with moderate hyperplasia (CM group), 75 patients in the experimental group with severe hyperplasia (EL group) and 60 patients in the control group with severe hyperplasia (CL group) according to the preoperative estimated prostate volume. The four groups were compared in terms of perioperative related indicators, glandular resection rate, incidence of postoperative complications, incidence of erectile dysfunction (ED) and ejaculatory dysfunction (EjD), as well as preoperative and post-operative scores on each evaluation scale, maximum urinary flow rate (Qmax), and residual urine volume (PVR). Results The differences were statistically significant when comparing the perioperative related indexes and glandular resection rates between the EM and CM groups, EL and CL groups, EM and EL groups, and CM and CL groups (all P< 0.05); the complication rates in the EM group were lower than those in the CM group, and those in the EL group were lower than those in the CL group, and the differences between the groups were statistically significant (χ2=3.888,6.371,all P<0.05). The incidence of ED and EjD in the experimental group were significantly lower than that in the control group, and the difference between the groups was statistically significant (χ2=66.024、 165.270, all P<0.05); postoperative Qmax, International Prostate Symptom Score (IPSS), Quality of Life Score (QoL), and PVR indexes in the experimental and control groups were all improved significantly compared with those before surgery; the differences in IIEF-5 scores and CIPE scores after surgery in the EM and EL groups were not statistically significant when compared with those before surgery (all P>0.05); the differences in IIEF-5 scores and CIPE scores after surgery in the EM and CM groups and in the EL and CL groups were statistically significant (t=12.351, 27.008, 6.167, 21.748, all P<0.05).  Conclusion M-TULIP has essentially equivalent surgical efficacy to TURP. However, M-TULIP has a lower tissue resection rate, better operative time, intraoperative bleeding, hospital stay and indwelling urethral catheter than TURP, and the incidence of postoperative urinary incontinence, EjD, ED and urethral stricture is significantly lower than that of TURP. Therefore, for patients with moderate to severe BHP, it is not necessary to pursue a higher resection ratio and resection weight. M-TULIP has clinical application advantages and is worth promoting.

基金项目:
?基金项目:攀枝花市科学技术局指导性科技计划项目 (项目编号:2021ZD-S-9)
作者简介:
参考文献:

 参考文献

[ 1 ] 王永忠,刘建平,梁胜军,等.老年人群前列腺体积与其剜除术后尿失禁发生的探讨[J]. 广州医科大学学报,2016,44(2):76-78.
[ 2  ] Hung MJ,Su TH,Lin YH,et al. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution[J]. J Sex Med,2015,11(9):2256-2263. 
[ 3 ] 孙玉成,何新洲,李进,等.腔内手术与开放手术治疗前列腺增生的疗效比较[J].临床泌尿外科杂志,2003,18(12):680-682.
[ 4 ] Gross JB. Estimating allowable blood loss:corrected for dilution[J]. Anesthesiology,1983,58(3):277–280.
[ 5 ] 郑少波,刘春晓,徐亚文,等.腔内剜除法在经尿道前列腺汽化电切术中的应用[J].中华泌尿外科杂志,2005,26(8):4.
[ 6 ] 陈忠,叶章群,吴嘉,等. 1 470 nm半导体激光汽化术治疗良性前列腺增生的疗效及安全性研究[J].中华泌尿外科杂志,2015(2):4.
[ 7 ] McNeal JE. Origin and evolution of benign prostatic enlargement[J]. Invest Urol,1978,15(4):340-345.
[ 8 ] 龙卫兵. TURP切除组织比例和切出腺窝形态与疗效关系的研究[D].南华大学,2010.
[ 9 ] Hakenberg OW,Helke C,Manseck A,et al. Is there a relationship between the amount of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia[J]. Euro Urol,2001,39(4):412-417.
[10] 李凌,彭泳涵,王则宇,等.“两点一线一面”的手术原则在钬激光前列腺剜除术中的应用研究[J].临床泌尿外科杂志,2017,32(4):5.
[11] 新馨.前列腺释疑[J].中国医药指南,2003(12):62-63.
[12] 张家华,季惠翔,包国华,等.经尿道保留尿道前壁前列腺剜除术的前瞻性随机双盲对照研究[J].第三军医大学学报,2016,38(3):5.
[13] 曲华伟,刘辉,刘京生,等. 160 W直束绿激光剥离汽化术治疗良性前列腺增生症[J].泌尿外科杂志:电子版,2015(3):4.
服务与反馈:
文章下载】【加入收藏
友情链接   中国知网-中国冶金工业医学杂志 搜狐邮箱 中国知网 中华预防医学会网站 国家新闻出版总署 博文采编官方网站 CNKI翻译助手 网易VIP163邮箱 网易126邮箱 网易163邮箱 雅虎邮箱 新浪邮箱 QQ邮箱 鞍钢总医院网站 丁香园 好医生 疾病查询

《中国冶金工业医学杂志》
编辑部地址:辽宁省鞍山市铁东区健身街3号(鞍钢总医院院内),邮编114002
电话:0412- 6327774 ,0412-6706630,传真:0412-6327774
网址:www.zgyjgyyxzz.com  邮箱:yjyx1984@vip.163.com
京ICP备10041176号